# Ground Truth Medical Form (GTMF)

## Patient Information

- **Subject ID**: 8948
- **Admission ID**: 155425
- **Row ID**: 10042
- **Profile Type**: FULL

## Demographics

- **Age**: 73
- **Sex**: F
- **Date of Birth**: 2042-08-01
- **Ethnicity**: WHITE
- **Marital Status**: WIDOWED
- **Religion**: UNOBTAINABLE
- **Insurance**: Medicare
- **Admission Type**: EMERGENCY
- **Admission Date**: 2116-03-06 18:08:00
- **Discharge Date**: 2116-03-09 16:10:00

## Chief Complaint

N/V/D, hyperglycemia

## Symptoms

- **nausea** | onset: after dinner yesterday | duration: through the night into the morning
- **vomiting (emesis, initially supper contents then dry heaves, no blood)** | onset: after dinner yesterday | duration: through the night into the morning
- **diarrhea (brown, no blood or black stool)** | onset: after dinner yesterday | duration: through the night into the morning
- **epigastric pain with emesis** | onset: with emesis
- **unable to tolerate much PO intake** | onset: after onset of GI symptoms
- **hyperglycemia**
- **acute renal failure**

## Medical History

Diabetes mellitus type 1, HTN, COPD, liver hemangioma, hyperthyroidism s/p radioactive iodine ablation, GERD, depression, osteomalacia, osteoporosis

## Allergies

Ace Inhibitors

## Current Medications

- **Insulin Glargine** | dosage: 20U qAM | frequency: once daily | purpose: basal insulin
- **Humalog** | dosage: sliding scale | frequency: as needed | purpose: meal-time insulin
- **ASA** | dosage: 325 mg | frequency: daily | purpose: antiplatelet
- **Combivent** | dosage: 4 puffs | frequency: QID | purpose: COPD
- **Celexa** | dosage: 40 mg | frequency: daily | purpose: antidepressant
- **Toprol XL** | dosage: 25 mg | frequency: daily | purpose: beta-blocker

## Discharge Medications

- **Aspirin** | dosage: 325 mg | frequency: daily
- **Metoprolol Succinate** | dosage: 25 mg | frequency: daily
- **Combivent** | dosage: 2 puffs | frequency: four times a day
- **Celexa** | dosage: 40 mg | frequency: once a day
- **Insulin Glargine** | dosage: 27 units | frequency: QAM
- **Insulin Lispro (Human)** | dosage: as directed per sliding scale | frequency: four times a day
- **Vitamin D** | dosage: 800 units | frequency: daily
- **Calcium carbonate** | dosage: 500 mg | frequency: TID with meals
- **Fosamax** | dosage: 70 mg | frequency: once weekly

## Diagnoses

- **Diabetic ketoacidosis (DKA)** | notes: History of DM1, presented with hyperglycemia, N/V/D, labs in ED with glucose 1142, bicarb 12, AG 33
- Diabetic ketoacidosis
- acute renal failure
- hypokalemia
- osteoporosis

## Treatment Options

### IV fluids and insulin drip

**Details**: Started in ED for DKA management
**Treatment**: IVF and insulin drip

### Calcium gluconate

**Details**: Given for initial hyperkalemia (K+ 6.7)
**Treatment**: Calcium gluconate

**Medications**:
- Calcium gluconate (not provided)

### IV hydration

**Details**: for DKA and acute renal failure

### insulin therapy

**Details**: insulin drip during admission, restarted on Glargine, sliding scale Humalog

**Medications**:
- Insulin Glargine (20U qAM on admission, 27U QAM at discharge)
- Insulin Lispro (Humalog) (as directed per sliding scale)

### osteoporosis management

**Details**: based on bone density study

**Medications**:
- Calcium carbonate (500 mg)
- Vitamin D (800 units)
- Fosamax (70 mg)
